AXRX Stock Overview

A pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. More details

AXRX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap ($338K)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Amexdrug Corporation Competitors

Acro Biomedical

OTCPK:ACBM

US$42.0k

PD-Rx Pharmaceuticals

OTCPK:PDRX

US$4.1m

Agape ATP

NasdaqCM:ATPC

US$5.2m

Virax Biolabs Group

NasdaqCM:VRAX

US$7.8m

Price History & Performance

Summary of share price highs, lows and changes for Amexdrug
Historical stock prices
Current Share Price	US$0.002
52 Week High	US$0.0021
52 Week Low	US$0.002
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-98.52%
5 Year Change	-96.05%
Change since IPO	-99.99%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	AXRX	US Healthcare	US Market
7D	0%	-2.9%	-0.3%
1Y	n/a	-5.4%	20.4%

Return vs Industry: Insufficient data to determine how AXRX performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how AXRX performed against the US Market.

Price Volatility

Is AXRX's price volatile compared to industry and market?
AXRX volatility
AXRX Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.9%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: AXRX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine AXRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1963	n/a	Jack Amin	www.amexdrug.com

Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products.

Amexdrug Corporation Fundamentals Summary

How do Amexdrug's earnings and revenue compare to its market cap?
AXRX fundamental statistics
Market cap	US$338.21k
Earnings (TTM)	US$165.83k
Revenue (TTM)	US$9.17m

0.0x

P/E Ratio

0.0x

P/S Ratio

Is AXRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AXRX income statement (TTM)
Revenue	US$9.17m
Cost of Revenue	US$7.90m
Gross Profit	US$1.27m
Other Expenses	US$1.10m
Earnings	US$165.83k

Last Reported Earnings

Jun 30, 2013

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AXRX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/19 05:14
End of Day Share Price	2024/10/23 00:00
Earnings	2013/06/30
Annual Earnings	2012/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Amexdrug Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.